Home People Richard Becker – Biography, Age, Medical Education, Career & Net Worth

Richard Becker – Biography, Age, Medical Education, Career & Net Worth

Richard Becker (born January 1954) is a board-certified American cardiologist in Cincinnati, Ohio. He subspecializes in interventional cardiology and vascular medicine.

Becker is the Director and Physician-in-Chief, University of Cincinnati College of Medicine Heart, Lung and Vascular Institute.

Richard Becker

Richard Becker Facts

  • Full Name: Richard Clinton Becker
  • Age: 69 years old
  • Date of Birth: January 1954
  • Occupation: Cardiologist
  • Nationality: American

Richard Becker Medical School & Residency

  • Cleveland Clinic Foundation, Fellowship Hospital — 1986
  • Cleveland Clinic Foundation, Residency Hospital — 1986
  • Cleveland Clinic Foundation, Internship Hospital — 1983
  • University of Cincinnati / Main Campus, Medical School — 1982

Richard Becker Career

Becker represents the American Heart Association on a national level. He currently concentrates his research on molecular platforms for drug discovery, such as RNA aptamers and drug-antidote combinations, enhanced proteomics, and gene expression profiles.

Certifications & Licensure

  • American Board of Internal Medicine – Certified in Internal Medicine
  • OH State Medical License – Active through 2023
  • MA State Medical License – Active through 2005
  • NC State Medical License – Active through 2014

Hospital Affiliations

  • University of Cincinnati Medical Center, Cincinnati, OH
  • West Chester Hospital, West Chester, OH

Specialty Expertise

Dr. Richard Becker has the following 16 areas of expertise

  • Cardiogenic Shock
  • Coronary Artery Bypass (Heart Bypass)
  • Deep Vein Thrombosis
  • Acute Coronary Syndrome (ACS)
  • Coronary Artery Angioplasty & Stent
  • Atherosclerosis
  • Inflammation
  • Myocardial Infarction
  • Blood Clot (Thromboembolism)
  • Coronary Disease
  • Vascular Disease
  • Heart Disease (Myocardial Ischemia)
  • Coronary Thrombosis
  • Coronary Artery Disease (CAD)
  • Arteriosclerosis (Arterial Disease)
  • Stroke

Insurance Accepted

  • Aetna Choice POS II
  • Aetna Health Network Option Open Access
  • Aetna HMO
  • Aetna Managed Choice POS Open Access
  • Aetna Signature Administrators PPO
  • Aexcel PPO
  • Ambetter Superior Health Plan
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • Anthem Blue Preferred Plus POS
  • BCBS Blue Card PPO
  • Buckeye Ambetter Balanced
  • CareSource Just4Me OH
  • CareSource Ohio
  • CIGNA Open Access Plus
  • First Health PPO
  • Humana Choice POS
  • Humana ChoiceCare Network PPO
  • Medmutual OhioHealth Network MRF
  • MMOH SuperMed HMO
  • MMOH SuperMed POS Select
  • MMOH SuperMed PPO Plus
  • Molina Mrktplace OH MRF
  • Molina place OH
  • Multiplan PPO
  • Sagamore Plus
  • UHC Choice Plus POS
  • UHC Navigate HMO
  • UHC Navigate POS
  • UHC Options PPO

Location & Contact Information

University Hospital Cardiovascular
234 Goodman St Fl 2
Cincinnati, OH 45219
(513) 475-8521

Fax: (513) 347-5748
Website: Universityhospitalcincinnati.com

University Of Cincinnati Health Cardiology
222 Piedmont Ave Ste 4000
Cincinnati, OH 45219
(513) 475-8521

Fax:(513) 347-5748

Expert Publications

Data provided by the National Library of Medicine

  • Intramural hematoma of the thoracic aorta in a woman with neurofibromatosis.
  • Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
  • Choice of agents to limit the coagulation cascade in acute coronary syndromes.
  • Antithrombotic therapy after myocardial infarction.
  • Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
  • Circadian variations in acute myocardial infarction: patients or health care
  • Factor Xa-A pleuripotential protease.
  • The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.
  • Plasmin-mediated proteolysis of vascular endothelial cell heparin releasable tissue factor pathway inhibitor.
  • Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
  • When guidelines collide…
  • Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapy.
  • Protein-binding oligonucleotides: the next frontier in antithrombotic therapy.
  • Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.
  • Thrombin: science and application in clinical practice
  • Richard Becker Net Worth

Richard Becker has an estimated net worth of $8 million.




Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.